Full text loading...
Therapeutic Research
Abstract
Background:Clinical characteristics in severe asthma patients have been studied well. Few studies have examined patient perception for asthma treatment and asthma disease in severe asthma patients. Object:To descriptively investigate patient satisfaction for current asthma treatment, perception for asthma treatment and subjective disease burden for asthma between severe asthma patients with biologics treatment(BIO treated patients)and severe asthma patients with biologics recommendation(BIO recommended patients). Method:This study was a cross‒sectional web survey of severe asthma patients aged≧20 years with, asthma diagnosis and one of three criteria for severe asthma(1:high dose inhaled corticosteroid and additional asthma treatment, 2:continuous oral corticosteroid use, 3:biologics use). Patient perception for asthma treatment and asthma disease was evaluated with original questionnaires. Results:Among 1247 severe asthma patients, 144 BIO treated patients and 48 BIO recommended patients were included. Proportion of patients with satisfaction for asthma treatment in BIO treated patients(65.3%)was higher than in BIO recommended patients(52.1%). Patient perception for current treatment with 10% or more difference between two groups is“good treatment”,“ continuous high efficacy”and“latest treatment”(higher in BIO treated patients)and“intention to continue current treatment to consider cost”(higher in BIO recommended patients). Conclusion:This is the first study to clarify patient satisfaction for current asthma treatment in BIO treated patients and BIO recommended patients. Improvements for severe asthma treatment are expected by consideration of patient perception of asthma treatment and asthma disease shown in this study.
Data & Media loading...